Virtus LifeSci Biotech Clinical Trials ETF (BBC) Chart & Stock Price History → The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad) Free BBC Stock Alerts $25.74 -0.33 (-1.27%) (As of 04/17/2024 ET) Add Compare Share Share ChartStock AnalysisChartHoldingsRatingsStock AnalysisChartHoldingsRatings Virtus LifeSci Biotech Clinical Trials ETF Stock Price Performance5 Day Performance-5.10%1 Month Performance-9.30%3 Month Performance+7.75%6 Month Performance+42.29%Year-To-Date Performance+5.27%1 Year Performance+10.17% Receive BBC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Virtus LifeSci Biotech Clinical Trials ETF and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Gold Safe ExchangeThe “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! BBC Stock Chart for Thursday, April, 18, 2024 BBC Chart by TradingView Virtus LifeSci Biotech Clinical Trials ETF Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/17/2024$26.07$25.74-1.27%$26.25$25.741,395 shs$10.30 million04/16/2024$26.38$26.07-1.18%$26.26$26.073,913 shs$13.04 million04/15/2024$27.12$26.38-2.74%$26.91$26.312,796 shs$13.19 million04/12/2024$27.94$27.72-0.79%$27.72$27.35543 shs$13.86 million04/11/2024$27.37$27.94+2.08%$27.94$27.64986 shs$13.97 million04/10/2024$27.86$27.37-1.76%$27.37$27.11800 shs$13.69 million Get the Latest News and Ratings for BBC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virtus LifeSci Biotech Clinical Trials ETF and its competitors with MarketBeat's FREE daily newsletter. 04/09/2024$27.47$27.86+1.42%$27.86$27.572,189 shs$13.93 million04/08/2024$27.38$27.47+0.34%$27.58$27.27772 shs$13.74 million04/05/2024$27.04$27.38+1.26%$27.38$27.25482 shs$13.69 million04/04/2024$27.67$27.04-2.28%$28.20$27.041,571 shs$13.52 million04/03/2024$27.56$27.67+0.40%$27.72$27.5232,275 shs$13.84 million04/02/2024$28.64$27.56-3.77%$28.35$27.561,280 shs$13.78 million04/01/2024$29.13$28.64-1.68%$28.77$28.313,940 shs$14.32 million03/29/2024$29.13$29.13$29.28$28.913,522 shs$14.57 million03/28/2024$28.99$29.13+0.48%$29.28$28.913,522 shs$14.57 million03/27/2024$28.34$28.99+2.28%$28.99$28.433,152 shs$14.50 million03/26/2024$28.26$28.34+0.30%$28.67$28.343,473 shs$14.17 million03/25/2024$28.74$28.26-1.68%$29.08$28.261,357 shs$14.13 million03/22/2024$29.26$28.74-1.78%$28.95$28.742,519 shs$14.37 million03/21/2024$29.22$29.26+0.14%$29.63$29.263,011 shs$14.63 million03/20/2024$28.63$29.22+2.06%$29.22$28.442,064 shs$14.61 million03/19/2024$28.38$28.63+0.88%$28.84$28.035,574 shs$14.32 million03/18/2024$29.18$28.38-2.74%$29.49$28.258,965 shs$14.19 million03/15/2024$28.79$29.18+1.35%$29.18$29.11849 shs$14.59 million03/14/2024$29.85$28.79-3.55%$29.68$28.475,602 shs$14.40 million03/13/2024$29.35$29.85+1.70%$29.85$29.243,896 shs$14.93 million03/12/2024$29.60$29.35-0.84%$29.68$29.273,853 shs$14.68 million03/11/2024$30.43$29.60-2.73%$30.45$29.508,062 shs$14.80 million03/08/2024$30.48$30.43-0.16%$31.20$30.423,391 shs$15.22 million03/07/2024$30.90$30.48-1.36%$31.37$30.4810,925 shs$15.24 million03/06/2024$30.61$30.90+0.95%$31.17$30.884,202 shs$15.45 million03/05/2024$30.94$30.61-1.07%$31.24$30.603,587 shs$15.31 million03/04/2024$31.35$30.94-1.31%$31.99$30.4120,820 shs$15.47 million03/01/2024$30.07$31.35+4.26%$31.48$30.5110,291 shs$15.68 million02/29/2024$30.67$30.07-1.97%$31.17$30.071,871 shs$15.04 million02/28/2024$30.98$30.67-0.98%$31.30$30.5710,030 shs$15.34 million02/27/2024$29.30$30.98+5.73%$30.98$29.757,797 shs$15.49 million02/26/2024$28.46$29.30+2.96%$29.30$28.602,520 shs$14.65 million02/23/2024$28.27$28.46+0.67%$28.56$28.367,026 shs$14.23 million02/22/2024$27.68$28.27+2.13%$28.51$28.271,559 shs$14.14 millionCould Bitcoin Literally FORCE This Crypto To Rocket Up? (Ad)Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is.02/21/2024$27.81$27.68-0.47%$27.68$27.54375 shs$13.84 million02/20/2024$28.64$27.81-2.90%$28.47$27.652,616 shs$13.91 million02/19/2024$28.64$28.64+0.01%$28.72$28.34500 shs$14.32 million02/16/2024$28.23$28.64+1.45%$28.72$28.34551 shs$14.32 million02/15/2024$27.67$28.23+2.02%$28.23$27.971,492 shs$14.12 million02/14/2024$26.87$27.67+2.97%$27.82$27.572,539 shs$13.84 million02/13/2024$28.20$26.87-4.71%$27.38$26.872,167 shs$13.44 million02/12/2024$27.48$28.20+2.63%$28.36$28.023,568 shs$14.10 million02/09/2024$26.73$27.47+2.77%$27.61$27.24976 shs$13.74 million02/08/2024$26.33$26.73+1.54%$26.73$26.72913 shs$13.37 million02/07/2024$26.57$26.33-0.92%$26.42$26.30843 shs$13.16 million02/06/2024$26.20$26.57+1.41%$26.58$26.3129,486 shs$13.29 million02/05/2024$25.83$26.20+1.41%$26.30$25.76834 shs$13.10 million02/02/2024$26.06$25.83-0.88%$25.83$25.455,611 shs$12.92 million02/01/2024$25.38$26.06+2.68%$26.08$25.222,891 shs$13.03 million01/31/2024$25.44$25.38-0.24%$25.75$25.381,710 shs$12.69 million01/30/2024$25.97$25.44-2.04%$25.85$25.401,840 shs$12.72 million01/29/2024$25.09$25.97+3.50%$25.97$24.961,604 shs$12.99 million01/26/2024$24.95$24.99+0.16%$25.48$24.992,144 shs$12.50 million01/25/2024$24.60$24.95+1.42%$25.18$24.703,923 shs$12.48 million01/24/2024$24.80$24.60-0.82%$25.06$24.60759 shs$12.30 million01/23/2024$24.72$24.80+0.34%$24.93$24.481,583 shs$12.40 million01/22/2024$23.89$24.72+3.48%$24.72$24.094,750 shs$12.36 million01/19/2024$23.89$23.89-0.01%$24.26$23.667,744 shs$11.94 million01/18/2024$24.35$23.89-1.89%$23.93$23.89809 shs$11.95 million01/17/2024$24.62$24.35-1.10%$24.35$24.22902 shs$12.18 million Related Companies: PILL Stock Chart JDOC Stock Chart MEDI Stock Chart MEDX Stock Chart BIS Stock Chart BBP Stock Chart HYLG Stock Chart KMED Stock Chart LGHT Stock Chart FTXH Stock Chart Receive BBC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virtus LifeSci Biotech Clinical Trials ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:BBC) was last updated on 4/18/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsUrgent alert: open this for a huge profit potentialTimothy SykesBiden out June 13; Kamala won’t replace him?Paradigm PressOptions trading has suddenly become more reliable.Eagle PublishingA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Clinical Trials ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.